Richard C. Effland - Concepedia

Author

Richard C. Effland

Vion Pharmaceuticals (United States)

Also Known As

R. C. EFFLAND, R. C. Effland, Richard C. Effland

Publications

384

Citations

H-Index

Concepts

All Affiliations

Vion Pharmaceuticals (United States)

About

Richard C. Effland is an author at Vion Pharmaceuticals (United States) specializing in pharmacology, natural sciences, and organic chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	7	7	113
2	Medicine	6	6	157
3	Biochemistry	3	3	66
4	Health Sciences	1	1	20
5	Allergy	1	1	60

Richard C. Effland

Publications

321

Citations

H-Index

Page 1

	Year	Citations
Synthesis and Structure−Activity Relationships of <i>N</i>-Propyl-<i>N</i>-(4-pyridinyl)-1<i>H</i>-indol-1-amine (Besipirdine) and Related Analogs as Potential Therapeutic Agents for Alzheimer's Disease Joseph Klein, Larry J. Davis, Gordon E. Olsen, Journal of Medicinal Chemistry	1996	62
Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents Robert W. Dunn, Denise M. Flanagan, Lawrence L. Martin, European Journal of Pharmacology AllergyStereoselective R-Functional SelectivityMedicineBehavioral Pharmacology	1992	60
[(3-Aryl-1,2-benzisoxazol-6-yl)oxy]acetic acids. A new diuretic series G. M. SHUTSKE, Linda L. Setescak, Richard C. Allen, Journal of Medicinal Chemistry	1982	35
Synthesis and Evaluation of 5-Amino-5,6,7,8-tetrahydroquinolinones as Potential Agents for the Treatment of Alzheimer's Disease David M. Fink, Gina M. Bores, Richard C. Effland, Journal of Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryBioorganic ChemistryBiochemistryPotential Agents	1995	31
Synthesis and preliminary structure-activity relationships of 1-[(3-fluoro-4-pyridinyl)amino]-3-methyl-1H-indol-5-yl methyl carbamate (P10358), a novel acetylcholinesterase inhibitor Lawrence L. Martin, Larry J. Davis, Joseph Klein, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryNatural SciencesMedicinePreliminary Structure-activity Relationships	1997	21
Mechanisms for the increase in electrically stimulated [<sup>3</sup>H]norepinephrine release from rat cortical slices by N‐(n‐propyl)‐N‐(4‐pyridinyl)‐1H‐indol‐1‐amine Craig P. Smith, Wayne W. Petko, Sathapana Kongsamut, Drug Development Research Synaptic TransmissionNeurotransmitterPharmacotherapyExperimental PharmacologyMolecular Pharmacology	1994	20
Synthesis of pyrrolo[2,1‐<i>c</i>][1,4]benzoxazepines. <b>1.</b> A novel heterocyclic ring system Richard C. Effland, Larry D. Davis Journal of Heterocyclic Chemistry DerivativesHeterocyclicMannich ReactionNatural SciencesAminoalkyl Derivatives	1985	15
Substituted (Pyrroloamino)pyridines: Potential Agents for the Treatment of Alzheimer's Disease Larry J. Davis, Gordon E. Olsen, Joseph Klein, Journal of Medicinal Chemistry Combinatorial ChemistryOrganic ChemistryNeurochemical BiomarkersScopolamine-induced DementiaChemistry	1996	14
Pyrrolo[2,1‐<i>c</i>][1,4]benzoxazepines. <b>2</b>. Synthesis of 5‐phenyl derivatives Kevin J. Kapples, Richard C. Effland Journal of Heterocyclic Chemistry Diversity Oriented SynthesisDerivativesHeterocyclicAnalogous CyclizationPiperidinyl Derivatives	1993	11
Synthesis of novel pyrido[3,4‐<i>f</i>]pyrrolo[1,2‐<i>b</i>][1,2,5]triazepines. A Novel heterocyclic ring system Richard C. Effland, Larry D. Davis, Kevin J. Kapples, Journal of Heterocyclic Chemistry Diversity Oriented SynthesisHeterocyclicNatural SciencesDiversity-oriented SynthesisNovel Pyrido	1990	11

Page 1